VMY-1-103 is a potent CDK inhibitor, is also a novel dansylated analog of purvalanol B, was shown to inhibit cell cycle progression and proliferation in prostate and breast cancer cells more effectively than purvalanol B. VMY-1-103 , but not purvalanol B
Molecular Weight:
708.27
CAS Number:
[1209002-43-6]
Formula:
C34H42ClN9O4S
* VAT and and shipping costs not included. Errors and price changes excepted
